Exemestane Tablet, Film Coated
Product Images NDC 63629-2056

4 FDA label images from Bryant Ranch Prepack · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Exemestane (NDC 63629-2056). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Exemestane 01)

Chemical Structure (Exemestane 01)
Chemical structure of exemestane, showing its steroidal core with methyl groups, double bonds, and ketone functional groups.*
FDA Label Image

Figure 1 (Exemestane 02)

Figure 1 (Exemestane 02)
A survival curve comparing the duration of disease-free survival in months between two treatments: Exemestane and Tamoxifen. The graph plots proportion surviving on the y-axis over time on the x-axis, with Exemestane showing higher survival proportion. The chart includes hazard ratio (HR 0.69, 95% CI 0.58-0.82) and p-value (0.00003) from a log-rank test, along with numbers of patients and events for each treatment group.*
FDA Label Image

Figure 2 (Exemestane 03)

Figure 2 (Exemestane 03)
A Kaplan-Meier survival curve comparing probability over weeks for Exemestane tablets and Megestrol acetate. The y-axis represents probability from 0 to 1, and the x-axis represents time in weeks from 0 to 150. The solid line shows data for Exemestane (270 PDs/366 patients), and the dashed line shows Megestrol acetate (305 PDs/403 patients). The chart depicts the decline in survival probability over time for both drugs.*
FDA Label Image

Label (Lbl636292056)

Label (Lbl636292056)
Label for Exemestane Tablets, USP 25 mg oral film-coated tablets, relabeled by Bryant Ranch Prepack, Inc. The label indicates the NDC 63629-2056-1 and package size of 30 tablets. Storage instructions and child-resistant container information are also present. The BRP Pharmaceuticals logo is shown on the label.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.